glp-1 without diabetes Taking GLP‑1 in 2026: What Real People Notice After 3, 6 and 12 Months The New Weight Management Meds

This indication affects about 22 million people in the U.S

Given the conflicting guidelines and lack of conclusive data surrounding perioperative care for patients using GLP-1 medications, the research team conducted a systematic review and meta-analysis of placebo-controlled studies, quantitatively assessing gastric emptying in adults treated for diabetes or excess body weight with GLP-1 medications, with the objective of providing insights relevant for guiding periprocedural management decisions

GLP-1 receptors (GLP1R), which are found in pancreatic beta cells as well as other cell types, receive the GLP-1 signal, triggering the release of insulin

In its first registrational Phase 3 obesity trial (TRIUMPH-1), average weight loss reached 28.3% at 80 weeks and up to 30.3% at 104 weeks in a select extension cohort